Human growth hormone replacement in adult hypopituitary patients: Long-term effects on body composition and lipid status - 3-year results from the hypoCCS database

Journal of Clinical Endocrinology and Metabolism

Volumn 87, Issue 4, 2002, Pages 1600-1606

  Attanasio, Andrea F ^a,b   Bates, Peter C ^a,b,c,d   Ho, Ken K Y ^a,b,c,d,e   Webb, Susan M ^a,b,c,d,e,f   Ross, Richard J ^{a,b,c,d,e,f,g}   Strasburger, Christian J ^a,b,c,d   Bouillon, Roger ^{a,b,c,d,e,f,g}   Crowe, Brenda ^a,b,c,d   Selander, Keith ^a,b,c,d,e,f   Valle, Domenico ^{a,b,c,d,e,f,g}   Lamberts, Steven W J ^{a,b,c,d,e,f,g,h}  

^a Eli Lilly Italia   (Italy)

^b ELI LILLY AND COMPANY   (United States)

^c GARVAN INSTITUTE OF MEDICAL RESEARCH   (Australia)

^d HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

^e NORTHERN GENERAL HOSPITAL   (United Kingdom)

^f UNIVERSITY OF MUNICH   (Germany)

^g Onderwijs en Navorsing   (Belgium)

^h Ziekenhuis Dijkzigt ^*

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HUMAN GROWTH HORMONE; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; AGED; ARTICLE; BODY COMPOSITION; BODY MASS; CHOLESTEROL BLOOD LEVEL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DATA BASE; DRUG EFFICACY; DRUG INDUCED DISEASE; DRUG SAFETY; FEMALE; GROWTH HORMONE DEFICIENCY; HUMAN; HYPOPITUITARISM; INTERNATIONAL COOPERATION; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; MULTICENTER STUDY; ONSET AGE; PRIORITY JOURNAL; SEX DIFFERENCE; TUMOR RECURRENCE;

ADULT; AGE OF ONSET; AGING; BODY COMPOSITION; FEMALE; HORMONE REPLACEMENT THERAPY; HUMAN GROWTH HORMONE; HUMANS; HYPOPITUITARISM; LIPIDS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; POPULATION SURVEILLANCE;

EID: 18444413530     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.87.4.1600     Document Type: Article

References (31)

1. Adult growth hormone (GH)-deficient patients demonstrate heterogeneity between childhood onset and adult onset before and during human GH treatment
2. Growth hormone replacement therapy in adult hypopituitary patients with growth hormone deficiency: Combined data from 12 European placebo-controlled clinical trials
3. Altered lipid pattern explains increased cardiovascular mortality in hypopituitary patients with growth hormone deficiency
4. Quality of life, body composition and muscle strength in adult growth hormone deficiency: The influence of growth hormone replacement therapy for up to 3 years
5. Dynamics of lipoprotein metabolism in adult growth hormone deficiency
6. Cardiovascular disease and risk factors in adults with hypopituitarism
7. Premature mortality due to cardiovascular disease in hypopituitarism
8. Increased cerebrovascular mortality in patients with hypopituitarism
9. The effect of hypopituitarism on life expectancy
10. Life expectancy following surgery for pituitary tumours
11. Is vascular mortality increased in hypopituitarism?
12. Growth hormone therapy for hypopituitary adults: Time for re-appraisal
13. Radioimmunoassays for IGFs and IGFBPs
14. The effects of treatment and the individual responsiveness to growth hormone (GH) replacement therapy in 665 GH-deficient adults
15. GH replacement in 1034 growth hormone deficient hypopituitary adults: Demographic and clinical characteristics, dosing and safety
16. Growth hormone deficiency in adulthood and the effects of growth hormone replacement: A review
17. The effects of 10 years of recombinant human growth hormone (GH) in adult GH-deficient patients
18. Effects of 7 years of growth hormone replacement therapy in hypopituitary adults
19. Evaluation of total and regional body composition
20. Does the age of onset of growth hormone deficiency affect cardiac performance? A radionuclide angiography study
21. Growth hormone (GH) treatment reverses early atherosclerotic changes in GH-deficient adults
22. Abnormal vascular reactivity in growth hormone deficiency
23. Primary prevention of coronary heart disease: Guidance from Framingham
24. Second report of the expert panel on detection, evaluation, and treatment of high blood cholesterol in adults
25. Cholesterol and coronary heart disease: Predicting risks by levels and ratios
26. Plasma lipids and cardiovascular risk: A POSCH report
27. A prospective study of 5 years of GH replacement therapy in GH deficient adults: Sustained effects on body composition, bone mass and metabolic indices
28. Body composition in growth hormone deficient adults over the age of 60 years
29. Growth hormone replacement therapy improves body composition and increases bone metabolism in elderly patients with pituitary disease
30. Growth hormone deficiency and replacement in elderly hypopituitary adults
31. Prospective multicenter safety surveillance of GH replacement in 2033 GH-deficient (GHD) adults